Lemon Bottle for Targeted Abdominal Fat Dissolving and Body Tightening

Name: Lemon Bottle for Targeted Abdominal Fat Dissolving and Body Tightening
Brand: OPALIS Biomedical Limited
SKU: 2178557082

Shandong, ChinaOPALIS Biomedical Limited

US$32.00

1-9 Pieces

US$28.00

10-19 Pieces

US$25.00

20-29 Pieces

US$20.00

30-99 Pieces

US$18.00

100+ Pieces

Product profile

Customization

Available

Certification

ISO

Disinfection

Model NO.

5*10ml

Color

Yellow

Application

Face Body

Material

Lecithin Bromelain Vitamin B2

Package

5*10ml

OEM/Private

Support

Storage Temperature

Storage at Room Temperature

Supply Type

OEM

MOQ

Transport Package

Box

Specification

5*10ml

Trademark

LemonBottle

Origin

China

Key features

Targeted Fat Reduction: Eliminates stubborn fat in face, waist, abdomen, thighs, arms, and hips.

Anti-Swelling Effect: Bromelain reduces edema, inflammation, and post-treatment discomfort.

Natural Ingredients: Contains Lecithin, Bromelain, and Vitamin B2 for enhanced metabolism.

OEM Support Available: Customization services supported for private label and OEM orders.

Company profile

OPALIS Biomedical LimitedShandong, China

Business Type: Manufacturer/Factory, Trading Company, Group CorporationExport Year: 2021-08-02Nearest Port: HongKong, QingDaoAverage Response Time: ≤1.52hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, DDP, EXW, CIF

AI-Powered supplier vetting

SummaryOPALIS Biomedical Limited is a China-based limited company in Qingdao, Shandong, described as a trading company, manufacturer/factory, and group corporation. It specializes in medical aesthetic products, including dermal fillers, hyaluronic acid gels, injections, collagen products, mesotherapy products, PLLA, skin boosters, and related items. The supplier reports ISO 9001 certification, 6–10 years of total R&D engineer experience, and two production lines. It also states that it provides OEM/ODM and customized products, supported by packaging design, consumables selection, custom formulations, and finished-product delivery. A 24-hour sales and after-sales service team is reported. The supplier claims that its products are popular in many countries, but no specific customer names, markets, order references, or case details are provided. Quality-control staffing is listed as n/a, so quality-control capacity cannot be assessed. Financial credibility cannot be assessed from the available non-financial evidence.

Supplier typeOPALIS Biomedical Limited is identified as a trading company, manufacturer/factory, and group corporation, with a limited-company ownership structure and operations in Qingdao, Shandong, China. This indicates a multi-role supplier profile, although the slices do not clarify the relative scale of its trading, manufacturing, or group activities.

CertificationsThe supplier explicitly reports certification under ISO 9001. This provides direct evidence of a certified quality-management system, although no certification scope, issuing body, or validity period is supplied.

After-Sales capabilityThe supplier states that it has a sales and after-sales team offering 24-hour service and welcomes customers to visit its factory. This is explicit evidence of stated continuous service availability, though staffing size and service-performance records are not provided.

R&D capabilityThe supplier reports 6–10 years of total R&D engineer experience and lists a broad range of medical aesthetic products, including dermal fillers, hyaluronic acid gels, collagen injections, mesotherapy, PLLA, skin boosters, and other products. This supports relevant product-development experience, but there is no direct evidence of patents, proprietary technologies, new-product launches, or dedicated R&D resources.

Customization capabilityThe supplier explicitly offers customized products and OEM/ODM processing, covering packaging design, consumables selection, custom formulations, and finished-product delivery. This indicates an end-to-end customization offering, although minimum order quantities, development timelines, and technical limitations are not stated.